best penny stocks

tags:WST,GPC,SUPV,BGCP,HCN,SUNS, &l;p&g;&l;img class=&q;dam-image getty size-large wp-image-961187446&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/961187446/960x0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; JINHUA, CHINA - MAY 21: Investors watch the electronic board at a stock exchange hall on May 21, 2018 in Jinhua, China. Chinese shares rose on Monday. The Shanghai Composite Index rose 21.01 points, or 0.66 percent, to close at 3,214.31. The Shenzhen Component Index rose 92.83 points, or 0.87 percent, to close at 10765.35 points. After the talk between Liu He, Vice-Premier of the State Council of the People&s;s Republic of China, and Steven Mnuchin, United States Secretary of the Treasury on Saturday, two sides agreed views on China-US ties and the economic and trade cooperation between the two countries by putting the trade war &a;iexcl;&a;reg;on hold.&a;iexcl;&a;macr; (Photo by VCG/VCG via Getty Images)

Over the past few weeks, I&a;rsquo;ve written about worthy REIT investments that have dividends over 6%, and 7%. And last week, my column reached for 8% and higher.

best penny stocks: West Pharmaceutical Services, Inc.(WST)

Advisors' Opinion:

• [By Ethan Ryder]

  West Pharmaceutical Services (NYSE: WST) and Carlisle Companies (NYSE:CSL) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

best penny stocks: Genuine Parts Company(GPC)

Advisors' Opinion:

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Genuine Parts (GPC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Bruderman Asset Management LLC lessened its stake in shares of Genuine Parts (NYSE:GPC) by 37.9% in the 1st quarter, Holdings Channel reports. The firm owned 4,091 shares of the specialty retailer’s stock after selling 2,495 shares during the quarter. Bruderman Asset Management LLC’s holdings in Genuine Parts were worth $368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• [By ]

  Genuine Parts Co. (NYSE: GPC)
  Ok, now I know I've definitely locked in the broken record award. GPC is better known to consumers as NAPA auto parts. And aftermarket auto parts is probably one of the most lucrative businesses in the United States for too many reasons to cover now.

• [By ]

  2. Price To Sales�
  Another useful metric is the price-to-sales ratio (P/S). P/S measures a company's market cap versus its annual revenue number. The idea is that the lower the number, the greater the implied value. For example, Snap, Inc. (Nasdaq: SNAP) trades at 26.9 times sales, an incredibly expensive number. However, aftermarket auto parts giant Genuine Parts (NYSE: GPC) trades at just 0.88 times sales -- 88 cents to every dollar of sales the company brings in. Often, the lower the number, the more inefficiently the market has mispriced the stock.

• [By Ethan Ryder]

  DekaBank Deutsche Girozentrale lessened its position in shares of Genuine Parts (NYSE:GPC) by 64.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,092 shares of the specialty retailer’s stock after selling 19,733 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Genuine Parts were worth $1,065,000 at the end of the most recent reporting period.

best penny stocks: Grupo Supervielle S.A. (SUPV)

Advisors' Opinion:

• [By Logan Wallace]

  Mckinley Capital Management LLC Delaware lowered its holdings in Grupo Supervielle (NYSE:SUPV) by 19.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 33,744 shares of the company’s stock after selling 7,984 shares during the quarter. Mckinley Capital Management LLC Delaware’s holdings in Grupo Supervielle were worth $1,023,000 as of its most recent SEC filing.

best penny stocks: BGC Partners, Inc.(BGCP)

Advisors' Opinion:

• [By ]

  Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

  Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

• [By Logan Wallace]

  LPL Financial (NASDAQ: LPLA) and BGC Partners (NASDAQ:BGCP) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

• [By ]

  BGC Partners (BGCP) : "We're in a market where Goldman Sachs (GS) got slammed. I'm going with them."

  Ecolab (ECL) : "That's a terrific situation that I want you to buy more of if it comes down."

best penny stocks: Welltower Inc.(HCN)

Advisors' Opinion:

• [By Shane Hupp]

  Welltower Inc (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

• [By Ethan Ryder]

  Welltower Inc (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

best penny stocks: Solar Senior Capital Ltd.(SUNS)

Advisors' Opinion:

• [By Joseph Griffin]

  Hercules Technology Growth Capital (NYSE: HTGC) and Solar Senior Capital (NASDAQ:SUNS) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings.

The Birth Of GDPR: What Is It And What You Need To Know

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1095986285&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1095986285/960x0.jpg?fit=scale&q; data-height=&q;639&q; data-width=&q;960&q;&g; Shutterstock

When you woke up this morning, you may have noticed that your email inbox has been flooded with emails from businesses and organizations informing you that they have &a;ldquo;updated their privacy policy&a;rdquo;.

The reason being is today, GDPR goes into effect and if a business isn&a;rsquo;t compliance, then hefty fines and penalties await.

&l;strong&g;What Is GDPR and Why Is It Necessary?&l;/strong&g;

The General Data Protection Regulation (&a;ldquo;&l;a href=&q;https://www.investopedia.com/terms/g/general-data-protection-regulation-gdpr.asp&q; target=&q;_blank&q;&g;GDPR&l;/a&g;&a;rdquo;) is a legal framework that requires businesses to protect the personal data and privacy of European Union (EU) citizens for transactions that occur within EU member states. It covers all companies that deal with the data of EU citizens, specifically banks, insurance companies, and other financial companies.

In April 2016, the European Parliament adopted the &l;a href=&q;http://data.consilium.europa.eu/doc/document/ST-5419-2016-INIT/en/pdf&q; target=&q;_blank&q;&g;GDPR&l;/a&g;, replacing its outdated &l;a href=&q;http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31995L0046:en:HTML&q; target=&q;_blank&q;&g;Data Protection Directive&l;/a&g;, enacted back in 1995. The problem with the Directive is that its no longer relevant to today&a;rsquo;s digital age. Its provisions fail to address how data is stored, collected, and transferred today&a;mdash;a digital age. Like many regulations and statutes throughout the EU and U.S., these regulations haven&a;rsquo;t been able to keep up with the pace of the levels of technological advancement.

The &l;a href=&q;http://ec.europa.eu/justice/data-protection/reform/files/regulation_oj_en.pdf&q; target=&q;_blank&q;&g;full text of GDPR&l;/a&g; is comprised of 99 articles, setting out the rights of individuals and obligations placed on businesses that are subject to the regulation. GDPR&a;rsquo;s provisions also require that any personal data exported outside the EU is protected and regulated. It is a very high standard to meet, requiring that companies invest large sums of money to ensure they are in compliance. According to the EU&a;rsquo;s GDPR website, the legislation is designed to &a;ldquo;harmonize&a;rdquo; data privacy laws across Europe, providing greater protection and rights to individuals.

Before the Internet, Europe has long been the model for how our data should be protected and regulated. The reason is that the public&a;rsquo;s concern over privacy has dominated the business sphere, ensuring that stringent rules on how companies use the personal data of its citizens is always taken into account.

Two days ago, the UK government created and enacted a new &l;a href=&q;http://www.legislation.gov.uk/ukpga/2018/12/contents/enacted&q; target=&q;_blank&q;&g;Data Protection Act&l;/a&g;, replacing the previous law that was passed into law back in 1998. Running 353 pages and full of complex provisions, it largely incorporates all the provisions of GDPR, but differs in that individual countries were able to select parts of GDPR that could be customized to their citizen&a;rsquo;s needs.

After months of learning about data breaches from companies like Facebook and Equifax, this couldn&a;rsquo;t be more necessary. Even Mark Zuckerberg jumped on board in his &l;a href=&q;https://www.cnet.com/news/facebook-zuckerberg-faces-more-cambridge-analytica-questions-on-capitol-hill-congress-senate/&q; target=&q;_blank&q;&g;testimony&l;/a&g; before Congress on Capitol Hill, believing GDPR to be a very positive step for the Internet.

&l;strong&g;What Data Is Protected Under GDPR?&l;/strong&g;

Pursuant to the GDPR, the following &l;a href=&q;http://www.wired.co.uk/article/what-is-gdpr-uk-eu-legislation-compliance-summary-fines-2018&q; target=&q;_blank&q;&g;types of data&l;/a&g; is addressed and covered:

(1) Personally identifiable information, including names, addresses, date of births, social security numbers

(2) Web-based data, including user location, IP address, cookies, and RFID tags

(3) Health (HIPAA) and genetic data

(4) Biometric data

(5) Racial and/or ethnic data

(6) Political opinions

(7) Sexual orientation

&l;strong&g;What Criteria Needs To Be Met?&l;/strong&g;

As mentioned earlier, the GDPR requirements comprise of a total of 99 articles--that&s;s alot of reading. Any company that stores or processes personal information about EU citizens within EU states must comply with the GDPR, even if they do not have a business presence within the EU. Companies are subject to GDPR if:

(1) The business has a presence in an EU country;

(2) Even if there is no presence in the EU, the company still processes personal data of European residents;

(3) There is more than 250 employees; and

(4) Even if there is fewer than 250 employees, if the data-processing impacts the rights and freedoms of its data subjects

&l;strong&g;How Do You Know If You Are Prepared?&l;/strong&g;

Well, individuals and businesses have had almost two years to figure out how to ensure their compliance, so there shouldn&s;t be an excuse for failure to comply. But, let&s;s be realistic, a large number of companies are going to get hit, hard. Today marks the day in which all that effort is broadcasted to the world of consumers.

&l;strong&g;#1 &a;ndash;Data Breach Incident Response Plan&l;/strong&g;

The biggest sign of readiness is having a data breach plan or incident response plan in place. While most companies have some form of a plan in place, they will need to review, amend, and update it, ensuring full compliance with GDPR requirements.

This is only half the battle. You better be prepared to enact it &l;em&g;when&l;/em&g; a data breach occurs. Testing these plans is essential, otherwise, how will you know if its actually ideal? The GDPR requires that companies report breaches within 72 hours, or 3 days. How well the data response team is able to implement the plan and minimize any damage will affect how much a company is fined and/or penalized.

&l;strong&g;#2 &a;ndash;Hiring A Data Protection Officer (DPO)&l;/strong&g;

The GDPR requires that a data protection officer (DPO) be appointed and hired. However, it doesn&a;rsquo;t address whether it needs to actually be a discrete position, so presumably, a company could name an officer who already has a similar role to that position, so long as they are able to show their protection of personally identifiable information (PII), with no conflict of interest. GDPR allows for the DPO to work for multiple organizations, lending support for a &a;ldquo;virtual DPO&a;rdquo; as an option.

&l;strong&g;#3 &a;ndash;Create a Record or Log of Risks and Compliance Progress&l;/strong&g;

Now that the clock has ticked its last tock, companies better have an updated record as to its progress made over the past two years, showing its identification of all its risks and measures taking in attempts of minimizing or eliminating those risks. This record, or Record of Processing Activities (&a;ldquo;RoPA&a;rdquo;), is required in Article 30 of GDPR, focusing on the inventory of risky applications and programs that may be operating.

However, another question presents itself in terms of the keeper of the log and how its maintained. The fear of manipulation, alteration, and fraud are still issues to be addressed. In the era of blockchain, having a log stored that&s;s stored on the blockchain that is unable to be manipulated or altered could prove extremely useful for companies moving forward.

&l;strong&g;How Does This Affect the US?&l;/strong&g;

&l;img class=&q;size-full wp-image-834&q; src=&q;http://blogs-images.forbes.com/andrewrossow/files/2018/05/IMG_8644.jpg?width=960&q; alt=&q;&q; data-height=&q;888&q; data-width=&q;1125&q;&g; Apple Mail

When it comes to US businesses, the GDPR requirements will force them to change the way they process, store, and protect customers&a;rsquo; personal data. Companies must provide a &a;ldquo;reasonable&a;rdquo; level of data protection and privacy to its customers, ensuring its storage only upon the individual consent by those customers and no longer than absolutely necessary for which the data is processed. However, the regulation doesn&a;rsquo;t define what &a;ldquo;reasonable&a;rdquo; means in terms of ensuring compliance, so this could present future complications when incidents occur and whether or not an organization took &l;em&g;enough&l;/em&g; steps to ensure minimal damage.

Upon request, companies must erase personal data&a;mdash;unlike the Cambridge Analytica and Facebook data breach that is still unfolding. The right to be forgotten is a powerful right and a right we as citizens are all entitled to. However, GDPR doesn&a;rsquo;t supersede any current legal requirement where an organization is required to maintain certain data, like HIPAA requirements.

https://www.wsj.com/articles/u-s-websites-go-dark-in-europe-as-gdpr-data-rules-kick-in-1527242038

&l;strong&g;How Does This Affect Social Media Companies?&l;/strong&g;

Your mind probably just jumped to Facebook and how this will affect social media networks. As we&a;rsquo;ve seen since Mark Zuckerberg&a;rsquo;s congressional hearing on Capitol Hill two months ago, many social media companies and online networks have already updated their privacy policies and terms of service in anticipation of today&a;rsquo;s deadline.

Facebook&a;rsquo;s response is going to be closely scrutinized by European regulators in wake of the Cambridge Analytica breach as well as lingering concerns over the company&a;rsquo;s data collection. Same with Twitter, yet no major scandal has put them in the public spotlight.

&l;u&g;Accountable EU Representative&l;/u&g;

If you think social media platforms are exempt from this regulation, you&a;rsquo;re thinking is also outdated. GDPR requires that social media companies have a &l;a href=&q;https://oursocialtimes.com/social-media-and-gdpr-is-your-brand-ready/&q; target=&q;_blank&q;&g;designated EU representative&l;/a&g; that can be held accountable for the GDPR compliance of the organization within Europe.

&l;u&g;Clear Privacy Notice&l;/u&g;

After hearing Zuckerberg&a;rsquo;s testimony, it&a;rsquo;s clear that users need to be presented with a simple and clear privacy notice that they can actually understand&a;mdash;not something that looks like a bulk collection of Harry Potter books bound together.

&l;u&g;The Right To Be Forgotten&l;/u&g;

It will be interesting to see how these companies will deal with user requests for deletion of certain personal data. It is no longer safe for a company to assume that their customers or users are content with their personal data being held&a;mdash;seeing as most of the have no idea it&a;rsquo;s held until something unfortunately happens.&l;strong&g;&a;nbsp;&l;/strong&g;

&l;strong&g;What Happens If You Fail To Comply With GDPR?&l;/strong&g;

Failing to adhere to the GDPR has steep penalties of up to &a;euro;20 million, or 4% of global annual turnover, whichever is higher.

Reports estimate that about half of U.S. companies that should be compliant on GDPR requirements by today, won&a;rsquo;t be. There&a;rsquo;s more to it than all those emails coming to your inbox about updated privacy terms.

According to a &l;a href=&q;https://www.csoonline.com/article/3202771/data-protection/general-data-protection-regulation-gdpr-requirements-deadlines-and-facts.html&q; target=&q;_blank&q;&g;December 2016 PwC survey&l;/a&g;, 68 percent of U.S. based companies expect to have spent $1-$10 million to meet these GDPR requirements.

&l;span&g;But, some websites in the U.S. have &l;a href=&q;https://gizmodo.com/dozens-of-american-news-sites-blocked-in-europe-as-gdpr-1826319542&q; target=&q;_blank&q;&g;decided to block their services&l;/a&g; entirely rather than adhere to the new regulations, going completely dark. Dozens of American newspapers are currently blocked in Europe and web services like Instapaper have suspended operations in the European Union for the foreseeable future.&l;/span&g;

Today is a big day for every business and organization in the world. Let&a;rsquo;s hope that the companies we are loyal to, are loyal to us.

&l;!--donotpaginate--&g;&l;/p&g;

Asian markets cautious after Trump cancels North Korea summit

Asian markets were mixed in cautious early trading Friday, after President Donald Trump canceled his upcoming summit with North Korean leader Kim Jong Un.

Japan��s Nikkei NIK, +0.11% � was off 0.1%, after initially dropping 0.5%, as the dollar JPYUSD, -0.294770% � pushed above 楼109.50 to session highs from 楼109.30. Commodity-related names were leading the way lower for Japanese stocks as they were poised to notch their first down week in two months. The marine-transportation sector was off 1.6%, the weakest performer in the Topix. Mining was off 1.1% following a sizable drop overnight in oil prices LCON8, -0.18% �. But that had the airline sector up 1%. Meanwhile, auto stocks were extending Thursday��s sharp selloff, with Honda 7267, -0.68% � and Toyota 7203, -1.25% � off nearly 1% more.

Hong Kong stocks started modestly weaker, with the Hang Seng Index HSI, -0.26% � off 0.4%, with energy stocks again a sore spot.

After a strong rebound Thursday, Singapore��s Straits Times Index STI, -0.03% � was down 0.3%, on the way to a second-straight weekly decline, which hasn��t happened since early February. Telecom stocks were down, with StarHub CC3, -1.89% � off nearly 1%. Weakness was also seen in bank and property names.

Malaysian stocks FBMKLCI, +1.04% � started strongly higher after two days of heavy selling.

Stocks in South Korea SEU, +0.01% � and Taiwan Y9999, +0.23% � were up modestly, while Australian stocks XJO, -0.06% � dipped lower.

We Want to Hear from You

Join the conversation

Comment Related Topics Asia Markets China Japan Australia Singapore Foreign Investment Quote References NIK +23.94 +0.11% JPYUSD -0.000027 -0.294770% LCON8 -0.14 -0.18% 7267 -24.00 -0.68% 7203 -90.00 -1.25% HSI -78.81 -0.26% STI -1.08 -0.03% CC3 -0.04 -1.89% FBMKLCI +18.39 +1.04% SEU +0.27 +0.01% Y9999 +24.96 +0.23% XJO -3.80 -0.06% Show all references MarketWatch Partner Center Most Popular GE��s stock suffers worst day in 9 years after CEO John Flannery starts talking If its ratings don��t really matter, why is Netflix suddenly canceling so many shows? Why early retirement is all it��s cracked up to be The fate of the S&P hangs in the balance �� and these 3 factors should decide it What to do in your 50s to build wealth for your retirement Community Guidelines �� FAQs BACK TO TOP MarketWatch Site Index Topics Help Feedback Newsroom Roster Media Archive Premium Products Mobile Company Company Info Code of Conduct Corrections Advertising Media Kit Advertise Locally Reprints & Licensing Your Ad Choices Dow Jones Network WSJ.com Barron's Online BigCharts Virtual Stock Exchange Financial News London WSJ.com Small Business realtor.com

Fibrogen Makes A Strong Case As An Acquisition Target After Latest Lung Fibrosis Data

Recently, Fibrogen (FGEN) announced updated results from its phase 2b study treating patients with idiopathic pulmonary fibrosis (IPF). It used its drug known as pamrevlumab, which is a monoclonal antibody, to treat these patients. I believe that these results reinforce the company's drug in this indication, and should be valued higher than it currently is. For these reasons, I believe that Fibrogen is a strong buy.

Phase 2b Data

The phase 2b study known as PRAISE used pamrevlumab to treat patients with idiopathic pulmonary fibrosis. This phase 2b IPF study tested efficacy between pamrevlumab and a placebo. One thing to note is that pulmonary fibrosis is a disease characterized as scarring of the lungs. The "idiopathic" word in front means that the cause of the scarring of the lungs is not known. In other words, it is something that occurs without a particular cause. Typically Doctors can sometimes identify a cause for lung fibrosis, but when they can't it is said to be idiopathic. It was shown that pamrevlumab was able to improve the measurement of Quantitative lung fibrosis (QLF) and FVC. In terms of QLF (lung fibrosis measurement), pamrevlumab was able to have a smaller change in QLF volume compared to placebo over a 48 week period. This was measured through the use of a non-invasive tool known as high-resolution computed tomography (HRCT). The QLF volume that was obtained with pamrevlumab was 24.8 ml versus 86.4 ml for placebo at week 24. That gives a p-value of p = 0.0090. The primary endpoint of the study was a change from baseline of Forced Vital Capacity (percent of predicted value at week 48) which was shown to be statistically significant with a p-value of p = 0.0001. FVC% is a measure of air a person is able to forcefully and quickly exhale after taking a deep breath. A Doctor can tell how well a lung works by comparing the FVC measurement taken with the predicted FVC value based on age, height, and weight. These were important findings from the study. Why is that? That's because there was a correlation that was observed between these two endpoints of the study. It was shown that a reduction of lung fibrosis was correlated with a change in FVC.

Market Opportunity For IPF

The market opportunity for idiopathic pulmonary fibrosis is massive. The global IPF market is expected to reach $4.6 billion by 2023. IPF is estimated to affect between 70,000 to 200,000 patients in the United States. As scarring of the lungs occurs, people eventually lose the capacity to be able to breathe. It is believed that death can occur at least two to five years after diagnosis. One current competitor is Roche (OTCQX:RHHBY) with its drug Esbriet. Roche wanted to get its hand on an IPF drug so bad, it bought Intermune back in 2014 for approximately $8.3 billion. Esbriet sales back in 2014 started at $48 million, and then brought in nearly $856 million in 2017. Eventually, it could reach sales in the billions. It now can be argued that Roche may have overpaid for this acquisition, but this brings me to a very important point. That point is the updated positive results obtained for Fibrogen in IPF, means that it now has a better probability of being acquired. Big pharma is on the hunt for big markets. The first market that big pharma is probably on the hunt for is NASH fibrosis acquisition as has been observed the last few years. I think that IPF offers an attractive investment opportunity. Which now brings out the next point, which is that pamrevlumab has an incredible mechanism of action profile. It is a monoclonal antibody that target connective tissue growth factor (CTGF). With that in mind, Fibrogen is using pamrevlumab to also go after other important indications. Pamrevlumab is also being explored for duchenne muscular dystrophy (DMD) and pancreatic cancer. Another strong clinical candidate in the pipeline is Roxadustat for anemia in chronic kidney disease (CKD) and in myelodysplastic syndrome (MDS). Both of these indications of Roxadustat have been partnered out. I think that all these indications, along with the highly positive IPF data makes Fibrogen a strong acquisition target.

Conclusion

The newly updated results from the phase 2b PRAISE study will allow Fibrogen to push forward with its clinical candidate pamrevlumab. After observing how much a big pharma is willing to pay for a single IPF product, it allows me to believe that a big premium could be obtained for Fibrogen. The reason why I feel this way is because when Roche acquired Intermune, it only did so because of Esbriet. However, Fibrogen has host of clinical products in the pipeline that could yield billions in market potential. Pamrevlumab by itself in IPF could eventually yield up to $4 billion in sales. That doesn't include the duchenne muscular dystrophy or pancreatic cancer indications. The cash position is strong for Fibrogen, because it has $730.4 million in cash as of March 31, 2018. In addition, the Roxadustat clinical candidate has already been partnered with AstraZeneca (AZN) for both indications. For all these reasons, I believe that Fibrogen is a strong buy.

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical investment research service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to my Service, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers deep dive analysis of many pharmaceutical companies throughout the biotech sector. Come see for yourself if my service is right for you.

Pricing: The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33.50% discount price of $399 per year.

Author's note: To get these types of premium articles on attractive biotech and pharma stocks as soon as they are published, just click here for my profile. Hit the big orange "Follow" button and choose the real-time alerts option thank you for taking the time to read my analysis.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

Top 10 Bank Stocks To Own Right Now

tags:EPAM,EDGE,BL,AMRK,EMD,KPTI,TEL,EXPD,VKI,INSY,

Raymore, MO, based Investment company Community Bank of Raymore buys General Electric Co, Apple Hospitality REIT Inc, E.I. du Pont de Nemours, Walt Disney Co, sells Anadarko Petroleum Corp during the 3-months ended 2017-06-30, according to the most recent filings of the investment company, Community Bank of Raymore. As of 2017-06-30, Community Bank of Raymore owns 47 stocks with a total value of $240 million. These are the details of the buys and sells.

New Purchases: DD, DIS, Added Positions: GE, APLE, LXP, Reduced Positions: JNJ, JPM, T, ALL, PG, RAI, WMT, CVX, VZ, Sold Out: APC,

For the details of Community Bank of Raymore's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Community+Bank+of+Raymore

These are the top 5 holdings of Community Bank of RaymoreHospitality Properties Trust (HPT) - 1,256,353 shares, 15.25% of the total portfolio. Shares added by 0.18%General Electric Co (GE) - 884,643 shares, 9.95% of the total portfolio. Shares added by 40.33%Realty Income Corp (O) - 399,541 shares, 9.18% of the total portfolio. Shares added by 0.35%GATX Corp (GATX) - 301,615 shares, 8.07% of the total portfolio. CSX Corp (CSX) - 332,753 shares, 7.56% of the total portfolio. New Purchase: E.I. du Pont de Nemours & Co (DD)

Community Bank of Raymore initiated holdings in E.I. du Pont de Nemours & Co. The purchase prices were between $76.56 and $83.88, with an estimated average price of $79.93. The stock is now traded at around $84.00. The impact to the portfolio due to this purchase was 0.13%. The holdings were 3,835 shares as of 2017-06-30.

Top 10 Bank Stocks To Own Right Now: EPAM Systems, Inc.(EPAM)

Advisors' Opinion:

• [By Dan Caplinger]

  Constant advances in technology require companies of all sizes to make efforts to keep up and take maximum advantage of new capabilities before competitors do. That puts companies like EPAM Systems (NYSE:EPAM) in a great position, because the resulting demand for IT services is constant and growing. EPAM did a good job of fulfilling its potential for strong growth in 2017, and the IT services specialist has high hopes that 2018 will bring even more gains.

Top 10 Bank Stocks To Own Right Now: Edge Therapeutics, Inc.(EDGE)

Advisors' Opinion:

• [By Logan Wallace]

  Edge Therapeutics (NASDAQ:EDGE) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday.

• [By Paul Ausick]

  Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 92.6% Wednesday to post a new 52-week low of $1.15. Shares closed at $15.59 on Tuesday and the stock’s 52-week high is $17.77. Volume was nearly 300 times the daily average of around 160,000 shares. The company ended a trial after reporting poor results.

• [By Paul Ausick]

  Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 14.5% Thursday to post a new 52-week low of $1.12. Shares closed at $1.31 on Wednesday and the stock’s 52-week high is $17.77. Volume was nearly 20 times the daily average of around 700,000 shares. The company on Wednesday ended a trial after reporting poor results and�shares fell more than 90% on the news.

Top 10 Bank Stocks To Own Right Now: BlackLine, Inc. (BL)

Advisors' Opinion:

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on BlackLine (BL)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By WWW.GURUFOCUS.COM]

  For the details of Silver Lake Group, L.L.C.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Silver+Lake+Group%2C+L.L.C.

  These are the top 5 holdings of Silver Lake Group, L.L.C.GoDaddy Inc (GDDY) - 15,868,908 shares, 21.3% of the total portfolio. Alibaba Group Holding Ltd (BABA) - 3,587,218 shares, 16.52% of the total portfolio. Sabre Corp (SABR) - 30,019,094 shares, 16.43% of the total portfolio. Broadcom Ltd (AVGO) - 1,618,567 shares, 11.1% of the total portfolio. BlackLine Inc (BL) - 12,543,873 shares, 10.99% of the total portfolio. Share
• [By WWW.GURUFOCUS.COM]

  For the details of Silver Lake Group, L.L.C.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Silver+Lake+Group%2C+L.L.C.

  These are the top 5 holdings of Silver Lake Group, L.L.C.GoDaddy Inc (GDDY) - 15,868,908 shares, 21.3% of the total portfolio. Alibaba Group Holding Ltd (BABA) - 3,587,218 shares, 16.52% of the total portfolio. Sabre Corp (SABR) - 30,019,094 shares, 16.43% of the total portfolio. Broadcom Ltd (AVGO) - 1,618,567 shares, 11.1% of the total portfolio. BlackLine Inc (BL) - 12,543,873 shares, 10.99% of the total portfolio. Share

Top 10 Bank Stocks To Own Right Now: A-Mark Precious Metals, Inc.(AMRK)

Advisors' Opinion:

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

Top 10 Bank Stocks To Own Right Now: Western Asset Emerging Markets Income Fund, Inc(EMD)

Advisors' Opinion:

• [By Joseph Griffin]

  Emerald Crypto (EMD) is a proof-of-work (PoW) coin that uses the
  Scrypt hashing algorithm. Its launch date was June 16th, 2013. Emerald Crypto’s total supply is 19,117,129 coins. Emerald Crypto’s official Twitter account is @Emerald_Crypto and its Facebook page is accessible here. Emerald Crypto’s official website is www.emeraldcrypto.de.

Top 10 Bank Stocks To Own Right Now: Karyopharm Therapeutics Inc.(KPTI)

Advisors' Opinion:

• [By Stephan Byrd]

  Karyopharm Therapeutics (NASDAQ:KPTI) – Investment analysts at Jefferies Group lowered their Q2 2018 earnings estimates for Karyopharm Therapeutics in a research note issued on Tuesday, May 15th. Jefferies Group analyst M. Raycroft now forecasts that the company will post earnings per share of ($0.77) for the quarter, down from their prior estimate of ($0.62). Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Karyopharm Therapeutics’ Q3 2018 earnings at ($0.71) EPS, Q4 2018 earnings at ($0.78) EPS, FY2018 earnings at ($3.03) EPS, FY2019 earnings at ($2.66) EPS, FY2020 earnings at ($1.05) EPS, FY2021 earnings at ($0.74) EPS and FY2022 earnings at $0.73 EPS.

• [By Stephan Byrd]

  Karyopharm Therapeutics (NASDAQ:KPTI) last issued its quarterly earnings data on Thursday, March 15th. The company reported ($0.80) EPS for the quarter, missing the consensus estimate of ($0.66) by ($0.14). The business had revenue of $1.53 million during the quarter, compared to the consensus estimate of $2.26 million. During the same quarter in the prior year, the firm posted ($0.65) earnings per share. The company’s revenue for the quarter was up 3163.8% compared to the same quarter last year. analysts anticipate that Karyopharm Therapeutics will post -2.82 earnings per share for the current fiscal year.

Top 10 Bank Stocks To Own Right Now: TE Connectivity Ltd.(TEL)

Advisors' Opinion:

• [By Logan Wallace]

  Robeco Institutional Asset Management B.V. lifted its stake in shares of TE Connectivity Ltd. (NYSE:TEL) by 0.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,295,222 shares of the electronics maker’s stock after purchasing an additional 10,957 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in TE Connectivity were worth $129,394,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Bank Stocks To Own Right Now: Expeditors International of Washington, Inc.(EXPD)

Advisors' Opinion:

• [By Lisa Levin] Companies Reporting Before The Bell Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion. Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion. Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion. Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion. Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million. The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion. Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion. US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion. DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion. Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million. Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion. Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion. Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion. JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
• [By Dan Caplinger]

  Tuesday saw an up-and-down session on Wall Street, with major benchmarks trading on either side of the unchanged mark before finishing the day flat. Many investors kept most of their attention on Washington, where the White House announced that the U.S. would withdraw from the deal that the previous administration made with Iran concerning nuclear development. The withdrawal was largely expected, and although crude oil and other commodities were volatile leading up to the final decision, most other financial markets seemed prepared for the announcement. Even on a lackluster day, some companies had good news that lifted their shares substantially. Expeditors International of Washington (NASDAQ:EXPD), Valeant Pharmaceuticals International (NYSE:VRX), and SeaWorld Entertainment (NYSE:SEAS) were among the best performers on the day. Here's why they did so well.

Top 10 Bank Stocks To Own Right Now: Invesco Advantage Municipal Income Trust II(VKI)

Advisors' Opinion:

• [By Ethan Ryder]

  Wedbush Securities Inc. bought a new stake in Invesco Advantage Municipal Income Trust II (NYSEAMERICAN:VKI) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 35,963 shares of the financial services provider’s stock, valued at approximately $382,000. Wedbush Securities Inc. owned 0.08% of Invesco Advantage Municipal Income Trust II as of its most recent SEC filing.

Top 10 Bank Stocks To Own Right Now: Insys Therapeutics, Inc.(INSY)

Advisors' Opinion:

• [By ]

  Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis - despite having donated to anti-marijuana advocacy groups in the past.

• [By Max Byerly]

  Get a free copy of the Zacks research report on Insys Therapeutics (INSY)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Casey Wilson]

  Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

• [By Keith Speights]

  In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.�For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

Tesla to Start Deliveries of Dual-Motor Model 3 in July

Tesla Inc. Chief Executive Officer Elon Musk has revealed the specifications for two new versions of the Model 3, the car that is intended to be the company’s first high-volume vehicle.

The performance version, and a less expensive dual-motor, all-wheel-drive option for the company’s Model 3 sedan come as Musk faces pressure from investors to reform Tesla’s nine-member board in the wake of production delays for the model. Deliveries will begin in July, he said in tweets posted Sunday.

The performance Model 3 -- also dual-motor and all-wheel-drive -- will have a 310-mile range, and accelerate from a standstill to 60 miles per hour in 3.5 seconds. For $78,000 excluding an autopilot option, customers can push the vehicle to a top speed of 155 miles per hour, Musk said on Twitter.

The cost is about the same as a BMW M3, “but 15 percent quicker and with better handling,” Musk said.

The cost of the normal dual-motor, AWD option is $5,000, Musk said. That version also has a range of 310 miles, but takes a second longer to reach 60 miles per hour and has a top speed of 140 mph. One motor is optimized for power and one for range, Musk said.

Tesla, whose Model 3 is set to compete with BMW AG’s 3-Series and upcoming i4 electric sedan, has repeatedly pushed back production targets and temporarily halted assembly lines to rework them.

Musk said Tesla owners will also soon be able to request ranger services -- when a technician comes to your car to fix it -- with a few taps on their phones.

Range Resources (RRC) Given Coverage Optimism Rating of 0.07

Media headlines about Range Resources (NYSE:RRC) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Range Resources earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave media headlines about the oil and gas exploration company an impact score of 46.3371462950661 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

Get Range Resources alerts: Why shareholders’ votes on methane emissions could lead to changes for drillers (bizjournals.com) Shareholders OK proposal calling on Range Resources to issue emissions management report (pionline.com) Methane shareholder resolution passes at U.S. oil and gas company (edf.org) Range shareholders approve measure to require methane report (bizjournals.com) Whirling Stocks: Range Resources Corporation (NYSE:RRC), Westport Fuel Systems Inc. (NASDAQ:WPRT), Ur-Energy … (thestreetpoint.com)

A number of equities analysts have issued reports on RRC shares. Morgan Stanley downgraded Range Resources from an “equal weight” rating to an “underweight” rating and set a $11.00 price objective for the company. in a report on Wednesday, January 24th. Credit Suisse Group decreased their price objective on Range Resources from $24.00 to $23.00 and set an “outperform” rating for the company in a report on Thursday, January 25th. Capital One downgraded Range Resources from an “overweight” rating to an “equal weight” rating in a report on Thursday, January 25th. Royal Bank of Canada decreased their price objective on Range Resources to $28.00 and set an “outperform” rating for the company in a report on Thursday, January 25th. Finally, Bank of America decreased their price objective on Range Resources from $23.00 to $22.00 and set a “neutral” rating for the company in a report on Thursday, January 25th. Five investment analysts have rated the stock with a sell rating, twelve have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Hold” and an average price target of $22.22.

Range Resources opened at $15.17 on Friday, Marketbeat reports. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.45 and a current ratio of 0.50. Range Resources has a one year low of $11.93 and a one year high of $25.96. The firm has a market cap of $3.85 billion, a P/E ratio of 26.16, a price-to-earnings-growth ratio of 1.03 and a beta of 0.56.

Range Resources (NYSE:RRC) last released its quarterly earnings data on Wednesday, April 25th. The oil and gas exploration company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.37 by $0.09. Range Resources had a return on equity of 4.36% and a net margin of 8.24%. The company had revenue of $742.60 million for the quarter, compared to analysts’ expectations of $725.60 million. During the same period last year, the firm posted $0.25 earnings per share. Range Resources’s revenue was down 4.4% compared to the same quarter last year. equities analysts anticipate that Range Resources will post 0.93 EPS for the current fiscal year.

Range Resources Company Profile

Range Resources Corporation operates as an independent natural gas, natural gas liquids (NGLs), and oil company. It engages in the exploration, development, and acquisition of natural gas and oil properties. It holds interests in developed and undeveloped natural gas and oil leases in the Appalachian and North Louisiana regions of the United States.